These studies provide evidence for the role of increased DPP4 and decreased BDNF in type 2-DM-related cognitive dysfunction [30], suggesting that DPP4 to BDNF ratio could be a novel biomarker for DM-related cognitive impairment [31]. The gene discussed is BDNF; the disease is Cognitive impairment.